Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study.

Arthritis Res Ther · 2015 · PMC4411723 · PMID 25885039

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The association showed a trend to be stronger in the patients taking methotrexate (Beta = 0.12), but the low number of patients in the group not taking this DMARD made the results inconclusive.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.